Coherus Biosciences | CHRS - Stock

Stock Price
1.61
Daily Change
-0.40 -19.90%
Monthly
0.63%
Yearly
36.44%
Q1 Forecast
2.39

Coherus Biosciences reported $2.05M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Akebia Therapeutics USD 18.64M 1.93M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Coherus Biosciences USD 2.05M 2.46M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Fujifilm JPY 600.12B 1.55B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Merck USD 6.44B 157M Sep/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025
Zoetis USD 2.43B 35M Dec/2025